ID   AGO2_RAT                Reviewed;         860 AA.
AC   Q9QZ81;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   14-NOV-2003, sequence version 2.
DT   02-OCT-2024, entry version 152.
DE   RecName: Full=Protein argonaute-2 {ECO:0000255|HAMAP-Rule:MF_03031};
DE            Short=Argonaute2 {ECO:0000255|HAMAP-Rule:MF_03031};
DE            EC=3.1.26.n2 {ECO:0000255|HAMAP-Rule:MF_03031};
DE   AltName: Full=Argonaute RISC catalytic component 2;
DE   AltName: Full=Eukaryotic translation initiation factor 2C 2 {ECO:0000255|HAMAP-Rule:MF_03031};
DE            Short=eIF-2C 2 {ECO:0000255|HAMAP-Rule:MF_03031};
DE            Short=eIF2C 2 {ECO:0000255|HAMAP-Rule:MF_03031};
DE   AltName: Full=Golgi ER protein 95 kDa;
DE            Short=GERp95;
DE   AltName: Full=Protein slicer {ECO:0000255|HAMAP-Rule:MF_03031};
GN   Name=Ago2; Synonyms=Eif2c2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Hepatoma;
RX   PubMed=10512872; DOI=10.1091/mbc.10.10.3357;
RA   Cikaluk D.E., Tahbaz N., Hendricks L.C., DiMattia G.E., Hansen D.,
RA   Pilgrim D., Hobman T.C.;
RT   "GERp95, a membrane-associated protein that belongs to a family of proteins
RT   involved in stem cell differentiation.";
RL   Mol. Biol. Cell 10:3357-3372(1999).
RN   [2]
RP   INTERACTION WITH AGO2 AND SND1.
RX   PubMed=24882364; DOI=10.1016/j.febslet.2014.05.031;
RA   Milochau A., Lagree V., Benassy M.N., Chaignepain S., Papin J.,
RA   Garcia-Arcos I., Lajoix A., Monterrat C., Coudert L., Schmitter J.M.,
RA   Ochoa B., Lang J.;
RT   "Synaptotagmin 11 interacts with components of the RNA-induced silencing
RT   complex RISC in clonal pancreatic beta-cells.";
RL   FEBS Lett. 588:2217-2222(2014).
CC   -!- FUNCTION: Required for RNA-mediated gene silencing (RNAi) by the RNA-
CC       induced silencing complex (RISC). The 'minimal RISC' appears to include
CC       AGO2 bound to a short guide RNA such as a microRNA (miRNA) or short
CC       interfering RNA (siRNA). These guide RNAs direct RISC to complementary
CC       mRNAs that are targets for RISC-mediated gene silencing. The precise
CC       mechanism of gene silencing depends on the degree of complementarity
CC       between the miRNA or siRNA and its target. Binding of RISC to a
CC       perfectly complementary mRNA generally results in silencing due to
CC       endonucleolytic cleavage of the mRNA specifically by AGO2. Binding of
CC       RISC to a partially complementary mRNA results in silencing through
CC       inhibition of translation, and this is independent of endonuclease
CC       activity. May inhibit translation initiation by binding to the 7-
CC       methylguanosine cap, thereby preventing the recruitment of the
CC       translation initiation factor eIF4-E. May also inhibit translation
CC       initiation via interaction with EIF6, which itself binds to the 60S
CC       ribosomal subunit and prevents its association with the 40S ribosomal
CC       subunit. The inhibition of translational initiation leads to the
CC       accumulation of the affected mRNA in cytoplasmic processing bodies (P-
CC       bodies), where mRNA degradation may subsequently occur. In some cases
CC       RISC-mediated translational repression is also observed for miRNAs that
CC       perfectly match the 3' untranslated region (3'-UTR). Can also up-
CC       regulate the translation of specific mRNAs under certain growth
CC       conditions. Binds to the AU element of the 3'-UTR of the TNF (TNF-
CC       alpha) mRNA and up-regulates translation under conditions of serum
CC       starvation. Also required for transcriptional gene silencing (TGS), in
CC       which short RNAs known as antigene RNAs or agRNAs direct the
CC       transcriptional repression of complementary promoter regions.
CC       {ECO:0000255|HAMAP-Rule:MF_03031}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Endonucleolytic cleavage to 5'-phosphomonoester.;
CC         EC=3.1.26.n2; Evidence={ECO:0000255|HAMAP-Rule:MF_03031};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC   -!- SUBUNIT: Interacts with DICER1 through its Piwi domain and with TARBP2
CC       during assembly of the RNA-induced silencing complex (RISC). Together,
CC       DICER1, AGO2 and TARBP2 constitute the trimeric RISC loading complex
CC       (RLC), or micro-RNA (miRNA) loading complex (miRLC). Within the
CC       RLC/miRLC, DICER1 and TARBP2 are required to process precursor miRNAs
CC       (pre-miRNAs) to mature miRNAs and then load them onto AGO2. AGO2 bound
CC       to the mature miRNA constitutes the minimal RISC and may subsequently
CC       dissociate from DICER1 and TARBP2. Note however that the term RISC has
CC       also been used to describe the trimeric RLC/miRLC. The formation of
CC       RISC complexes containing siRNAs rather than miRNAs appears to occur
CC       independently of DICER1. Interacts with AGO1. Also interacts with DDB1,
CC       DDX5, DDX6, DDX20, DHX30, DHX36, DDX47, DHX9, ELAVL, FXR1, GEMIN4,
CC       HNRNPF, IGF2BP1, ILF3, IMP8, MATR3, PABPC1, PRMT5, P4HA1, P4HB, RBM4,
CC       SART3, TNRC6A, TNRC6B, UPF1 and YBX1. Interacts with the P-body
CC       components DCP1A and XRN1. Associates with polysomes and messenger
CC       ribonucleoproteins (mNRPs). Interacts with RBM4; the interaction is
CC       modulated under stress-induced conditions, occurs under both cell
CC       proliferation and differentiation conditions and in an RNA- and
CC       phosphorylation-independent manner. Interacts with LIMD1, WTIP and
CC       AJUBA. Interacts with TRIM71; the interaction increases in presence of
CC       RNA. Interacts with APOBEC3G in an RNA-dependent manner. Interacts with
CC       APOBEC3A, APOBEC3C, APOBEC3F and APOBEC3H. Interacts with DICER1,
CC       TARBP2, EIF6, MOV10 and RPL7A (60S ribosome subunit); they form a large
CC       RNA-induced silencing complex (RISC). Interacts with FMR1. Interacts
CC       with ZFP36. Interacts with RC3H1; the interaction is RNA independent
CC       (By similarity). Found in a complex, composed of AGO2, CHD7 and ARB2A
CC       (By similarity). Interacts with SND1 and SYT11 (PubMed:24882364).
CC       Interacts with CLNK (By similarity). Interacts with GARRE1 (By
CC       similarity). Interacts with GRB2; this interaction is important for the
CC       formation of a ternary complex containing GRB2, AGO2 and DICER1 (By
CC       similarity). {ECO:0000250|UniProtKB:Q8CJG0,
CC       ECO:0000250|UniProtKB:Q9UKV8, ECO:0000255|HAMAP-Rule:MF_03031,
CC       ECO:0000269|PubMed:24882364}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, P-body {ECO:0000255|HAMAP-
CC       Rule:MF_03031}. Nucleus {ECO:0000255|HAMAP-Rule:MF_03031}.
CC       Note=Translational repression of mRNAs results in their recruitment to
CC       P-bodies. Translocation to the nucleus requires IMP8.
CC       {ECO:0000255|HAMAP-Rule:MF_03031}.
CC   -!- DOMAIN: The Piwi domain may perform RNA cleavage by a mechanism similar
CC       to that of RNase H. However, while RNase H utilizes a triad of Asp-Asp-
CC       Glu (DDE) for metal ion coordination, this protein appears to utilize a
CC       triad of Asp-Asp-His (DDH). {ECO:0000255|HAMAP-Rule:MF_03031}.
CC   -!- PTM: Hydroxylated. 4-hydroxylation appears to enhance protein stability
CC       but is not required for miRNA-binding or endonuclease activity.
CC       {ECO:0000255|HAMAP-Rule:MF_03031}.
CC   -!- PTM: Ubiquitinated on surface-exposed lysines by a SCF-like E3
CC       ubiquitin-protein ligase complex containing ZSWIM8 during target-
CC       directed microRNA degradation (TDMD), a process that mediates
CC       degradation of microRNAs (miRNAs). Ubiquitination by the SCF-like E3
CC       ubiquitin-protein ligase complex containing ZSWIM8 leads to its
CC       subsequent degradation, thereby exposing miRNAs for degradation. ZSWIM8
CC       recognizes and binds AGO2 when it is engaged with a TDMD target.
CC       {ECO:0000250|UniProtKB:Q9UKV8}.
CC   -!- PTM: Phosphorylation at Ser-388 by AKT3; leads to up-regulate
CC       translational repression of microRNA target and down-regulate
CC       endonucleolytic cleavage. {ECO:0000250|UniProtKB:Q9UKV8}.
CC   -!- PTM: A phosphorylation cycle of C-terminal serine cluster (Ser-825-Ser-
CC       835) regulates the release of target mRNAs. Target-binding leads to
CC       phosphorylation of these residues by CSNK1A1, which reduces the
CC       affinity of AGO2 for mRNA and enables target release. The ANKRD52-PPP6C
CC       phosphatase complex dephosphorylates the residues, which primes AGO2
CC       for binding a new target. {ECO:0000250|UniProtKB:Q9UKV8}.
CC   -!- SIMILARITY: Belongs to the argonaute family. Ago subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_03031}.
CC   -!- CAUTION: Was originally thought to be membrane-associated.
CC       {ECO:0000305|PubMed:10512872}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF12800.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF195534; AAF12800.1; ALT_INIT; mRNA.
DR   RefSeq; NP_067608.1; NM_021597.1.
DR   AlphaFoldDB; Q9QZ81; -.
DR   SMR; Q9QZ81; -.
DR   BioGRID; 248738; 1.
DR   IntAct; Q9QZ81; 7.
DR   MINT; Q9QZ81; -.
DR   STRING; 10116.ENSRNOP00000011898; -.
DR   iPTMnet; Q9QZ81; -.
DR   PhosphoSitePlus; Q9QZ81; -.
DR   jPOST; Q9QZ81; -.
DR   PaxDb; 10116-ENSRNOP00000011898; -.
DR   PeptideAtlas; Q9QZ81; -.
DR   UCSC; RGD:621255; rat.
DR   AGR; RGD:621255; -.
DR   RGD; 621255; Ago2.
DR   eggNOG; KOG1041; Eukaryota.
DR   InParanoid; Q9QZ81; -.
DR   OrthoDB; 3060088at2759; -.
DR   PhylomeDB; Q9QZ81; -.
DR   Reactome; R-RNO-203927; MicroRNA (miRNA) biogenesis.
DR   Reactome; R-RNO-426486; Small interfering RNA (siRNA) biogenesis.
DR   Reactome; R-RNO-426496; Post-transcriptional silencing by small RNAs.
DR   Reactome; R-RNO-5578749; Transcriptional regulation by small RNAs.
DR   PRO; PR:Q9QZ81; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0033391; C:chromatoid body; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; IDA:RGD.
DR   GO; GO:0036464; C:cytoplasmic ribonucleoprotein granule; IBA:GO_Central.
DR   GO; GO:0010494; C:cytoplasmic stress granule; IDA:RGD.
DR   GO; GO:0005829; C:cytosol; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0070062; C:extracellular exosome; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:RGD.
DR   GO; GO:0016020; C:membrane; IDA:RGD.
DR   GO; GO:0005739; C:mitochondrion; IDA:BHF-UCL.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0043186; C:P granule; IDA:RGD.
DR   GO; GO:0000932; C:P-body; ISO:RGD.
DR   GO; GO:0071546; C:pi-body; IDA:RGD.
DR   GO; GO:0098794; C:postsynapse; ISO:RGD.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IDA:RGD.
DR   GO; GO:0016442; C:RISC complex; IDA:RGD.
DR   GO; GO:0070578; C:RISC-loading complex; ISS:UniProtKB.
DR   GO; GO:0001046; F:core promoter sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0003725; F:double-stranded RNA binding; ISO:RGD.
DR   GO; GO:0090624; F:endoribonuclease activity, cleaving miRNA-paired mRNA; ISO:RGD.
DR   GO; GO:0070551; F:endoribonuclease activity, cleaving siRNA-paired mRNA; ISS:UniProtKB.
DR   GO; GO:0030544; F:Hsp70 protein binding; IDA:RGD.
DR   GO; GO:0051879; F:Hsp90 protein binding; IDA:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0035198; F:miRNA binding; ISO:RGD.
DR   GO; GO:0035925; F:mRNA 3'-UTR AU-rich region binding; ISO:RGD.
DR   GO; GO:0003729; F:mRNA binding; ISO:RGD.
DR   GO; GO:0098808; F:mRNA cap binding; ISS:UniProtKB.
DR   GO; GO:1905172; F:RISC complex binding; IDA:RGD.
DR   GO; GO:0000340; F:RNA 7-methylguanosine cap binding; ISS:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; ISO:RGD.
DR   GO; GO:0004521; F:RNA endonuclease activity; ISO:RGD.
DR   GO; GO:0000993; F:RNA polymerase II complex binding; ISO:RGD.
DR   GO; GO:0003727; F:single-stranded RNA binding; ISO:RGD.
DR   GO; GO:0035197; F:siRNA binding; ISS:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; NAS:RGD.
DR   GO; GO:0071277; P:cellular response to calcium ion; IEP:RGD.
DR   GO; GO:0010586; P:miRNA metabolic process; ISO:RGD.
DR   GO; GO:0035196; P:miRNA processing; ISO:RGD.
DR   GO; GO:0035278; P:miRNA-mediated gene silencing by inhibition of translation; ISS:UniProtKB.
DR   GO; GO:0035279; P:miRNA-mediated gene silencing by mRNA destabilization; ISS:UniProtKB.
DR   GO; GO:0042985; P:negative regulation of amyloid precursor protein biosynthetic process; IMP:ARUK-UCL.
DR   GO; GO:0045947; P:negative regulation of translational initiation; ISS:UniProtKB.
DR   GO; GO:0033962; P:P-body assembly; ISO:RGD.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:1900153; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; ISS:UniProtKB.
DR   GO; GO:0060213; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; ISS:UniProtKB.
DR   GO; GO:1900370; P:positive regulation of post-transcriptional gene silencing by RNA; IMP:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0045727; P:positive regulation of translation; ISO:RGD.
DR   GO; GO:1901165; P:positive regulation of trophoblast cell migration; ISO:RGD.
DR   GO; GO:0009791; P:post-embryonic development; ISO:RGD.
DR   GO; GO:0031054; P:pre-miRNA processing; ISS:UniProtKB.
DR   GO; GO:0043488; P:regulation of mRNA stability; IMP:RGD.
DR   GO; GO:0090128; P:regulation of synapse maturation; ISO:RGD.
DR   GO; GO:0031047; P:regulatory ncRNA-mediated gene silencing; ISS:UniProtKB.
DR   GO; GO:0035194; P:regulatory ncRNA-mediated post-transcriptional gene silencing; IBA:GO_Central.
DR   GO; GO:0042220; P:response to cocaine; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0043278; P:response to morphine; IEP:RGD.
DR   GO; GO:0070922; P:RISC complex assembly; ISO:RGD.
DR   GO; GO:0010501; P:RNA secondary structure unwinding; ISO:RGD.
DR   GO; GO:0030422; P:siRNA processing; ISO:RGD.
DR   GO; GO:0090625; P:siRNA-mediated gene silencing by mRNA destabilization; ISO:RGD.
DR   GO; GO:0007283; P:spermatogenesis; IEP:RGD.
DR   CDD; cd02846; PAZ_argonaute_like; 1.
DR   CDD; cd04657; Piwi_ago-like; 1.
DR   Gene3D; 3.40.50.2300; -; 1.
DR   Gene3D; 2.170.260.10; paz domain; 1.
DR   Gene3D; 3.30.420.10; Ribonuclease H-like superfamily/Ribonuclease H; 1.
DR   HAMAP; MF_03031; AGO2; 1.
DR   InterPro; IPR028602; AGO2.
DR   InterPro; IPR014811; ArgoL1.
DR   InterPro; IPR032472; ArgoL2.
DR   InterPro; IPR032473; Argonaute_Mid_dom.
DR   InterPro; IPR032474; Argonaute_N.
DR   InterPro; IPR003100; PAZ_dom.
DR   InterPro; IPR036085; PAZ_dom_sf.
DR   InterPro; IPR003165; Piwi.
DR   InterPro; IPR045246; Piwi_ago-like.
DR   InterPro; IPR012337; RNaseH-like_sf.
DR   InterPro; IPR036397; RNaseH_sf.
DR   PANTHER; PTHR22891; EUKARYOTIC TRANSLATION INITIATION FACTOR 2C; 1.
DR   PANTHER; PTHR22891:SF59; PROTEIN ARGONAUTE-2; 1.
DR   Pfam; PF08699; ArgoL1; 1.
DR   Pfam; PF16488; ArgoL2; 1.
DR   Pfam; PF16487; ArgoMid; 1.
DR   Pfam; PF16486; ArgoN; 1.
DR   Pfam; PF02170; PAZ; 1.
DR   Pfam; PF02171; Piwi; 1.
DR   SMART; SM01163; DUF1785; 1.
DR   SMART; SM00949; PAZ; 1.
DR   SMART; SM00950; Piwi; 1.
DR   SUPFAM; SSF101690; PAZ domain; 1.
DR   SUPFAM; SSF53098; Ribonuclease H-like; 1.
DR   PROSITE; PS50821; PAZ; 1.
DR   PROSITE; PS50822; PIWI; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Endonuclease; Hydrolase; Hydroxylation; Magnesium; Manganese;
KW   Metal-binding; Nitration; Nuclease; Nucleus; Phosphoprotein;
KW   Reference proteome; Repressor; Ribonucleoprotein; RNA-binding;
KW   RNA-mediated gene silencing; Transcription; Transcription regulation;
KW   Translation regulation; Ubl conjugation.
FT   CHAIN           1..860
FT                   /note="Protein argonaute-2"
FT                   /id="PRO_0000194060"
FT   DOMAIN          230..349
FT                   /note="PAZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00142"
FT   DOMAIN          518..819
FT                   /note="Piwi"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03031"
FT   REGION          312..317
FT                   /note="Interaction with guide RNA"
FT                   /evidence="ECO:0000250"
FT   REGION          525..567
FT                   /note="Interaction with guide RNA"
FT                   /evidence="ECO:0000250"
FT   REGION          588..591
FT                   /note="Interaction with GW182 family members"
FT                   /evidence="ECO:0000255"
FT   REGION          651..661
FT                   /note="Interaction with GW182 family members"
FT                   /evidence="ECO:0000255"
FT   REGION          710..711
FT                   /note="Interaction with guide RNA"
FT                   /evidence="ECO:0000250"
FT   REGION          754..762
FT                   /note="Interaction with guide RNA"
FT                   /evidence="ECO:0000250"
FT   REGION          791..813
FT                   /note="Interaction with guide RNA"
FT                   /evidence="ECO:0000250"
FT   BINDING         598
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03031"
FT   BINDING         670
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03031"
FT   BINDING         808
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03031"
FT   MOD_RES         2
FT                   /note="3'-nitrotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CJG0, ECO:0000255|HAMAP-
FT                   Rule:MF_03031"
FT   MOD_RES         388
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UKV8"
FT   MOD_RES         701
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03031"
FT   MOD_RES         825
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UKV8"
FT   MOD_RES         829
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UKV8"
FT   MOD_RES         832
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UKV8"
FT   MOD_RES         835
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UKV8"
SQ   SEQUENCE   860 AA;  97318 MW;  A5B0798C66481C9C CRC64;
     MYSGAGPVLA SPAPTTSPIP GYAFKPPPRP DFGTTGRTIK LQANFFEMDI PKIDIYHYEL
     DIKPEKCPRR VNREIVEHMV QHFKTQIFGD RKPVFDGRKN LYTAMPLPIG RDKVELEVTL
     PGEGKDRIFK VSIKWVSCVS LQALHDALSG RLPSVPFETI QALDVVMRHL PSMRYTPVGR
     SFFTASEGCS NPLGGGREVW FGFHQSVRPS LWKMMLNIDV SATAFYKAQP VIEFVCEVLD
     FKSIEEQQKP LTDSQRVKFT KEIKGLKVEI THCGQMKRKY RVCNVTRRPA SHQTFPLQQE
     SGQTVECTVA QYFKDRHKLV LRYPHLPCLQ VGQEQKHTYL PLEVCNIVAG QRCIKKLTDN
     QTSTMIRATA RSAPDRQEEI SKLMRSASFN TDPYVREFGI MVKDEMTDVT GRVLQPPSIL
     YGGRNKAIAT PVQGVWDMRN KQFHTGIEIK VWAIACFAPQ RQCTEVHLKS FTEQLRKISR
     DAGMPIQGQP CFCKYAQGAD SVEPMFRHLK NTYAGLQLVV VILPGKTPVY AEVKRVGDTV
     LGMATQCVQM KNVQRTTPQT LSNLCLKINV KLGGVNNILL PQGRPPVFQQ PVIFLGADVT
     HPPAGDGKKP SIAAVVGSMD AHPNRYCATV RVQQHRQEII QDLAAMVREL LIQFYKSTRF
     KPTRIIFYRD GVSEGQFQQV LHHELLAIRE ACIKLEKEYQ PGITFIVVQK RHHTRLFCTD
     KNERVGKSGN IPAGTTVDTK ITHPTEFDFY LCSHAGIQGT SRPSHYHVLW DDNRFSSDEL
     QILTYQLCHT YVRCTRSVSI PAPAYYAHLV AFRARYHLVD KEHDSAEGSH TSGQSNGRDH
     QALAKAVQVH QDTLRTMYFA
//
